176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
40.34%
Revenue growth above 1.5x MU's 19.75%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
43.22%
Gross profit growth at 75-90% of MU's 53.11%. Bill Ackman would demand operational improvements to match competitor gains.
101.58%
EBIT growth 1.25-1.5x MU's 88.03%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
101.58%
Operating income growth 1.25-1.5x MU's 88.03%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
114.23%
Net income growth 1.25-1.5x MU's 84.23%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
108.33%
EPS growth 1.25-1.5x MU's 83.95%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
110.00%
Diluted EPS growth 1.25-1.5x MU's 81.82%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.75%
Share count expansion well above MU's 0.64%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.49%
Diluted share count expanding well above MU's 1.47%. Michael Burry would fear significant dilution to existing owners' stakes.
-2.34%
Dividend reduction while MU stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
148.91%
OCF growth above 1.5x MU's 71.32%. David Dodd would confirm a clear edge in underlying cash generation.
176.32%
FCF growth under 50% of MU's 390.52%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
140.01%
10Y revenue/share CAGR at 50-75% of MU's 199.43%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
112.09%
5Y revenue/share CAGR at 75-90% of MU's 128.76%. Bill Ackman would encourage strategies to match competitor’s pace.
105.29%
3Y revenue/share CAGR above 1.5x MU's 34.85%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
55.57%
10Y OCF/share CAGR under 50% of MU's 2076.03%. Michael Burry would worry about a persistent underperformance in cash creation.
111.44%
5Y OCF/share CAGR at 50-75% of MU's 213.22%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
204.65%
3Y OCF/share CAGR above 1.5x MU's 59.60%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
400.09%
Net income/share CAGR at 50-75% of MU's 609.55%. Martin Whitman might question if the firm’s product or cost base lags behind.
243.06%
Below 50% of MU's 559.45%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
392.86%
3Y net income/share CAGR above 1.5x MU's 97.14%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
183.48%
10Y equity/share CAGR above 1.5x MU's 42.73%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
51.19%
5Y equity/share CAGR at 50-75% of MU's 84.81%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
33.04%
3Y equity/share CAGR at 50-75% of MU's 56.95%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.76%
3Y dividend/share CAGR of 51.76% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
29.35%
AR growth well above MU's 20.96%. Michael Burry fears inflated revenue or higher default risk in the near future.
30.33%
Inventory growth well above MU's 2.13%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
28.83%
Asset growth above 1.5x MU's 2.82%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
17.96%
BV/share growth of 17.96% while MU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
101.92%
We have some new debt while MU reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
6.57%
We increase R&D while MU cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
8.92%
SG&A growth well above MU's 9.09%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.